This inventor holds 1 USPTO granted patent. Top assignee: Nissan Chemical Industries Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Shinya Naitou: Innovator in Pharmaceutical Chemistry
Introduction
Shinya Naitou is a prominent inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods for producing optically active compounds. His work is essential for developing intermediates used in various pharmaceutical applications.
Latest Patents
Naitou holds a patent for a method for producing optically active 5-hydroxy-3-ketoester. The objective of this invention is to provide a method that yields high quantities of this compound with excellent stereoselectivity. This optically active 5-hydroxy-3-ketoester is valuable as an intermediate in pharmaceutical synthesis. The novel method involves an asymmetric aldol reaction using a 1,3-diene compound in the presence of an optically active binaphthol-titanium complex, along with a substituted nitrogen-containing aromatic heterocyclic compound. This innovative approach results in a high yield of the desired compound.
Career Highlights
Shinya Naitou is associated with Nissan Chemical Industries Limited, where he applies his expertise in chemical synthesis and innovation. His work has been instrumental in advancing the company's capabilities in pharmaceutical chemistry. Naitou's dedication to research and development has led to significant advancements in the production of optically active compounds.
Collaborations
Naitou has collaborated with notable colleagues, including Shouichi Tateyama and Yasutaka Takada. These collaborations have fostered a productive research environment, leading to innovative solutions in the field of chemistry.
Conclusion
Shinya Naitou's contributions to pharmaceutical chemistry through his innovative methods and collaborations highlight his importance in the field. His patent for producing optically active 5-hydroxy-3-ketoester exemplifies his commitment to advancing pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile